{"id":"W4386350420","doi":"10.1016/j.hpb.2023.07.756","title":"Trial in Progress: Atezolizumab and Bevacizumab Pre-liver Transplantation for Patients with Hepatocellular Carcinoma beyond Milan Criteria","year":2023,"lang":"en","type":"article","venue":"HPB","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Milan criteria; Hepatocellular carcinoma; Bevacizumab; Atezolizumab; Liver transplantation; Internal medicine; Cirrhosis; Transplantation; Surgery; Oncology; Cancer; Gastroenterology; Chemotherapy; Nivolumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002304087,0.001439746,0.002818786,0.000367513,0.0005484683,0.002173299,0.000841308,0.002009684,0.005473667],"category_scores_gemma":[0.002741681,0.0004415895,0.003669047,0.0005108365,0.0009264254,0.00193568,0.0008935806,0.006465624,0.0009463117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001271621,"about_ca_system_score_gemma":0.001818234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001352638,"about_ca_topic_score_gemma":0.003257975,"domain_scores_codex":[0.9991486,0.0004755242,0.00005678336,0.0001079614,0.00005326835,0.0001578551],"domain_scores_gemma":[0.9982474,0.0004415273,0.0003822511,0.0001330106,0.0001102086,0.0006856369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9170389,0.003062271,0.008042525,0.0007349359,0.003154677,0.00009373462,0.00006855601,0.0007537545,0.001670135,0.000554454,0.007286515,0.05753954],"study_design_scores_gemma":[0.9039555,0.06398395,0.01694981,0.0002685405,0.002465671,0.0001813221,0.00009043743,0.0009615683,0.0006740551,0.0007917467,0.00962021,0.00005732731],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9366509,0.02641806,0.001866773,0.01692299,0.003508645,0.001609479,0.005464717,0.0001945828,0.007363806],"genre_scores_gemma":[0.9353991,0.01326573,0.004795332,0.01126226,0.003724758,0.003599258,0.01463745,0.00009436205,0.01322179],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.005473667,"threshold_uncertainty_score":0.01831126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0345084265809307,"score_gpt":0.2631201585445158,"score_spread":0.2286117319635851,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}